High-flying Eli Lilly plots $15B share buyback plan
Fierce Pharma
DECEMBER 10, 2024
Tue.Dec 10, 2024
204 
Safety Stands Out in Arcellx Cell Therapy’s ASH Data, But Don’t Overlook Manufacturing Advantages
MedCity News
DECEMBER 10, 2024
Arcellxs cell therapy for multiple myeloma has shown no signs of the parkinsonism complication observed in clinical testing of Carvykti, a rival product from partners Johnson & Johnon and Legend Biotech. Arcellx is developing its CAR T-treatment under a partnership with Gilead Sciences. The post Safety Stands Out in Arcellx Cell Therapys ASH Data, But Dont Overlook Manufacturing Advantages appeared first on MedCity News.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
CSL Vifor floats £23M offer, doctor outreach campaign in bid to resolve UK antitrust probe
Fierce Pharma
DECEMBER 10, 2024
CatalYm shows potential of visugromab for treating cachexia
PharmaTimes
DECEMBER 10, 2024
New findings presented at international SCWD conference
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
More Than 70 Organizations Urge Congress to Extend Enhanced Premium Tax Credits
MedCity News
DECEMBER 10, 2024
In a letter, Families USA and numerous other organizations called on Congress to extend the enhanced premium tax credits that are set to expire at the end of 2025. The post More Than 70 Organizations Urge Congress to Extend Enhanced Premium Tax Credits appeared first on MedCity News.
GSK’s multiple myeloma ADC Blenrep was pulled from the market. Now, it’s poised for a comeback.
PharmaVoice
DECEMBER 10, 2024
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis
PharmaTimes
DECEMBER 10, 2024
New cell therapy shows potential in treating advanced blood disorder
Is Your SEO Strategy Outdated? The Critical Shift to AI and Intent-Driven Search in Healthcare
Healthcare Success
DECEMBER 10, 2024
Did you know Google changes its algorithm up to 200 times a day? Yet many healthcare organizations still rely on SEO strategies and tactics that were "best practices" a decade ago. Its no surprise that countless healthcare providers and other businesses are seeing drops in rankings and traffic after Google's Helpful Content Update. To help you navigate these changes and learn what you need to update, I invite you to listen to this podcast featuring Brandon Schakola.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
ASH 2024: Regeneron’s Ordspono faces challenges, but positive results signal hope
Pharmaceutical Technology
DECEMBER 10, 2024
While 88.
New Amsterdam stock jumps as LDL-C lowering drug scores again at Phase III
Pharmaceutical Technology
DECEMBER 10, 2024
The results from the Phase III trial found the LDL-C treatment to be well tolerated with a reduction in low-density lipoprotein cholesterol.
How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
RSV prophylactic market to reach $6.2bn in 8MM by 2030
Pharmaceutical Technology
DECEMBER 10, 2024
The respiratory syncytial virus (RSV) prophylaxis market across the eight major markets (8MM) - comprising the US, the five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and Australia - is forecast to grow from $582m in 2020 to $6.2bn in 2030 at a compound annual growth rate of 26.7%, with the paediatric and adult segments accounting for $2.2bn and $4.0bn, respectively.
Pharmacy Leaders Eye Opportunities, Challenges for Legislation in the Year Ahead
Pharmacy Times
DECEMBER 10, 2024
The progress made in areas like scope expansion and reimbursement is encouraging, suggesting a growing recognition of pharmacists value within the health care system.
EMA validates Chiesi and Protalix’s dose variation for Fabry disease
Pharmaceutical Technology
DECEMBER 10, 2024
The EMA has validated Chiesi Global Rare Diseases and Protalixs submission to update the dosing regimen of pegunigalsidase alfa.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
PharmExec
DECEMBER 10, 2024
When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Santhera’s DMD therapy Agamree approved for NHS use after new price deal
Pharmaceutical Technology
DECEMBER 10, 2024
An improved price discount and new evidence from Santhera has changed NICEs tune following a recommendation shun earlier this year.
What Every Pharma CEO Should Know About Unlocking Scientific Data Potential
PharmExec
DECEMBER 10, 2024
When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
FDA to review GSK’s Nucala for COPD
Pharmaceutical Technology
DECEMBER 10, 2024
The US FDA has accepted a submission from GSK to review a new indication of Nucala (mepolizumab) as an add-on maintenance treatment for COPD.
Trade & Channel Strategies 2024: Evolving with the Times
Pharmaceutical Commerce
DECEMBER 10, 2024
A panel uncovers how distribution channels are aligning commercialization efforts.
Increase Revenue With Better, Faster Sales Onboarding
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Seres’ SER-155 gains breakthrough status for BSIs reduction
Pharmaceutical Technology
DECEMBER 10, 2024
Seres Therapeutics has received US FDA breakthrough therapy designation for its SER-155, aimed at decreasing BSIs.
Trade & Channel Strategies 2024: Access and Channel 2024 Year-in-Review and Preview of 2025
Pharmaceutical Commerce
DECEMBER 10, 2024
Conference keynote speech examines the industrys critical developments of 2024 and offers a strategic outlook for next year.
Enzene on New Technologies and New Jersey Site Capabilities
PharmaTech
DECEMBER 10, 2024
Shilpa Gadgil, PhD (VP, Head of Process and Analytical Development, Head of CDMO Development) discusses Enzene's new technologies and the New Jersey site capabilities.
Climbing the Ladder: Career Progression in Medical Sales with MNCs in Malaysia
Contrarian Sales Techniques
DECEMBER 10, 2024
When you think of medical sales in a multinational pharmaceutical company (MNC), you might picture a fast-paced, target-driven job. But heres the thing: Its not just about hitting quotas or visiting doctors. If you play your cards right, medical sales can be the start of a career that takes you to regional or even global leadership roles. So, how does career progression look in medical sales for an MNC in Malaysia?
Traceability's Latest Curve
Pharmaceutical Commerce
DECEMBER 10, 2024
Our December analysis of the twists and turns in the Drug Supply Chain Security Act is a timely one, as the FDA recently again pushed back the deadline for complying with new mandates on tracking and tracing drugs at the package level.
Omnicom to Acquire Interpublic Group to Create Premier Marketing and Sales Company
PM360
DECEMBER 10, 2024
NEW YORK , Dec. 9, 2024 /PRNewswire/ — Omnicom (NYSE: OMC ) and The Interpublic Group of Companies, Inc. (NYSE: IPG ) (“Interpublic”) today announced their Boards of Directors have unanimously approved a definitive agreement pursuant to which Omnicom will acquire Interpublic in a stock-for-stock transaction. The combined company will bring together the industry’s deepest bench of marketing talent, and the broadest and most innovative services and products, driven by the m
Pharmaceutical Commerce - December 2024 Issue (PDF)
Pharmaceutical Commerce
DECEMBER 10, 2024
Click the title above for a link to open the Pharmaceutical Commerce December 2024 issue in an interactive PDF format.
Pistoia Alliance Survey Finds 85% of Life Science Professionals are Concerned About the Impact of Differing AI Regulations on Cross-Border Collaboration
Copyright Clearance Center
DECEMBER 10, 2024
London, 10 December 2024: The Pistoia Alliance , a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has announced the results of a global survey in conjunction with CCC (Copyright Clearance Center), a leader in advancing copyright, accelerating knowledge, and powering innovation, on the impact of AI and copyright legislation on pharma R&D.
Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Let's personalize your content